Shionogi & Co., Ltd.

4507.T
Drug Manufacturers - Specialty & Generic
2026/08/21 Updated
Market Cap: $15.7B (¥2.5T)
Stock Price: $18.45 (¥2,933)
Exchange Rate: 1 USD = ¥158.98

Initiatives Toward Realizing Management that Considers Capital Cost and Stock Price

Shionogi & Co., Ltd. is promoting the enhancement of management functions, operational efficiency, and corporate strategies aimed at realizing management that takes into account capital costs and stock prices. The company aims to maximize corporate value through proactive IR activities and management review.

Importance:
Page Updated: June 24, 2026
IR Disclosure Date: June 24, 2026

Key Figures

  • Research and Development Expenses: Unknown
  • Number of Overseas Investor Responses: Unknown
  • Number of IR Briefings Held: 58 times/year

AI要約

Overview of Management

Shionogi & Co., Ltd. is advancing the enhancement of corporate functions and operational efficiency to realize management that considers capital costs and stock prices. As part of their mid- to long-term management strategy, they are strengthening global business development and research and development, while aiming to reinforce their management foundation and maximize corporate value. The company actively conducts IR activities, including 58 briefings per year and responses to overseas investors, deepening dialogue with shareholders and investors.

Future Outlook and Impact on Investors

Moving forward, the company plans to deepen management that considers capital costs and stock prices, while further advancing corporate functions, streamlining operations, and enhancing corporate value. By expanding IR activities and strengthening overseas investor responses, they aim to maximize shareholder returns and corporate value. The company is committed to investor dialogue and expects to achieve long-term stock price stability and growth.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shionogi & Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →